Abstract
This study was undertaken to establish the role of cytokines (IL-1, IL-2, IL-4, IL-6, and TNF) in the pathogenesis and the clinical course of childhood ALL. A total of 150 children with ALL (88 boys and 62 girls, aged from 0.5 to 15 years) were included in the study. TNF production was studied in supernatants deriving from 24-h PBSC mononuclear culture using the method based on growth inhibition of mice fibroblasts sensitive to TNF α 929, IL-1 production using a method based on inhibition of autologous rosette formation by CBA mouse thymocytes, and IL-2, IL-4, and IL-6 production using a conventional ELISA Genzyme test. Thirty-nine healthy children served as the control group. TNF and IL-1 production decreased after starting chemotherapy for ALL, while a relative increase of IL-6 was observed. It was found that, in children with ALL, IL-1 production, was significantly lower during the whole of therapy than that observed in the control group of healthy children (p = 0.005). No IL-2 and IL-4 production was observed in children with ALL during the 2.5-year period of observation. After cessation of therapy IL-1 and TNF production rose, while IL-6 production remained on the same level. During the 10-year period after the end of therapy IL-1 median values did not reach the values of the control group. EFS at 73 months in ALL children with IL-1 production <10 units before therapy was better than that observed in children with production >10 units (90.48% v 76.19%; p = 0.005). EFS at 65 months in ALL children with no detectable TNF production before therapy was better than that observed in children with detectable TNF production (92.31% v 72.73%; n.s.). EFS at 55 months in ALL children with IL-4 production >400 pg/ml before therapy was better than that observed in children with production <400 pg/ml (80% v 64.26%; n.s.). IL-1, IL-4, and TNF production could be useful prognostic factors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Minamishima I., Ohga S., Ishii E., Matsuzaki A., Kai T., Akazawa K., Ueda K. (1993) Serum interleukin-6 and fever at diagnosis in children with acute leukemia. Am J Pediatr Hematol Oncol, Vol. 15, No. 2, 1993
Ouazz F., Menz F., Mossalayi M.D., Schmitt C., Michel A., Debre P., Guillosson J-J, Merle-Beral H., Arock M. (1994) Interleukin 4 inhibits the proliferation and promotes the maturation of human leukemic early B cells. Eur J Haematol: 51:276–281.
Ferrajoli A., Zipf T.F., Talpaz M., Felix E.A., Estrov Z. (1993) Growth factors controlling interleukin-4 action on hematopoietic progenitors. Ann Hematol 67: 277–284
Jewell A.P., Yong K.L., Worman C.P., Giles F.J., Goldstone A.H., Lydyard P.M. (1992) Cytokine induction of leucocyte adhesion molecule-1 (LAM-1) expression on chronic lymphocytic leuukaemia cells. Leukemia, 6,5:400–404
Janssen R.A., Mulder N.H., Hauw The T., de Leij L. (1994) The immunobiological effects of interleukin-2 in vivo. Cancer Immunol Immunother 39: 207–216
Griffiths S.D., Cawley J.C. (1990) The effect of cytokines, including IL-1, IL-4, and IL-6, in hairy cell proliferation/differentation. Leukemia, 4, 5: 337–340
Namunaitis J. (1994) Growth factors of the future. Leuke Lymphoma, 9: 329–336
Carter A., Haddad N., Draxler I., Tatarsky I. (1994) Effects of soluble interleukin-1 receptor and tumor-necrosis factor receptor, respectively, on the IL-1 and TNF-α-induced DNA synthesis of acute myeloblastic leukemia blasts in vitro. Eur J Haematol: 53: 38–45.
Börset M., Waage A., Brekke O.L., Helseth E. (1994) TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line. Eur J Haematol; 53:31–37.
Aguilar-Santelises M., Magnusson R., Svenson, S.B., Loftennuis A., Anderson B., Mellstedt H., Jondal M., (1991) Expression of interleukin 1 alfa, interleukin 1 beta and interleukin -6 in chronic B lymphocytic leukaemia -B-CLL) cells from patients at different stages of disease progression. Clin. Exp. Immunol, 84, 422–428
Akira S., Kishmoto T., (1992) IL-6 and TNF IL-6 in acute phase response and viral infection. Immunol. Rev. 127, 25–50.
Baigrie R.J, lamont P.M, Dallman M., Morris P.J, (1991) The release of interleukin-1 beta (IL-1) precedes that of interleukin-6 (IL-6) in patients undergoing major surgery. Lymphokine Cytokine Res, 10, 4 253–256
Balkwill F., Burke F., Talbot D., Tavernier J., Osborne R., Naylor S., Durbin H., Fiers W. (1987): Evidence for tumor necrosis factor/cachectin production in cancer. Lancet 28: 1229–1232.
Bauer J., Herrman F. (1991) Interleukin-6 in clinical medicine. Ann Hematol 62, 203–210
Bocci V., (1991) Interleukins. Clinical pharmacokinetics and practical implications. Clin. Pharmacokinet. 21, 274–284
Boer E.C., Jong H.W, Steerengberg P.A., Aarden L.A., Tetteroo E., Groot E.R., Van der Mejden A.P.M., Vegt P.D.J, Degruyne F.M, Ruitenberg E.J., (1992) Induction of urinary interleukin -1 (IL-1), IL-2, IL-6 and tumor necrosis factor during intravesical immunotherapy with bacillus Calmette-Guerin in superficial bladder cancer. Cancer Immunol. Immunother. 34, 306–312
Carter A., Merchav S., Silvian-Draxler I., Tatarsky I. (1990): The role of interleukin-1 and tumor necrosis factor-a in human multiple myeloma. Br.J. Haematol 74: 424–431.
Chybicka A., Boguslawska-Jaworska J. (1990): Interleukin-1 Production in Childhood Acute Lymphoblastic Leukemia During Chemo- and Radiotherapy According to BFM protocols. In: Acute Leukemia II. Ed: Büchner T., Schellong G., Hiddemann W., Ritter J. Hematology and Blood Transf. Springer-Verlag 133: 72-75.
Chybicka A, Boguslawska-Jaworska J., Budzynski W., Radzikowski Cz., Jaworski W. (1992), IL-1 production by mononuclear cell and NK cell activity in children with ALL Hematol. and Blood Transf.-Acute Leukemias ed Kusche/Hiddemann Springer-Verlag
Danis V.A., Franic G.M., Rathjen D.A., Brooks P.M. (1991) Effects of granulocyte macrophage colony stimulating factor (GM-CSF), IL-2, interferon gamma (IFNgamma), tumor necrosois factor alfa (TNF alfa) and IL-6 on the production of immunoreactive IL-1 and TNF alfa by human monocytes. Clin. Exp. Immunol. 85,143–150
Fibbe E., Schaafsma M.R., Falkenburg F.J., Willemze R. (1989) The biological activities of interleukin 1. Blut, 59:147.
Grau G.E. (1990): Implications of cytokines in immunopathology experimental and clinical data. Eur. Cytokine Net., 1,203–210
Hamilton I.A. (1993) Colony stimulating factors, cytokines and monocyte-macrophages-some contronversies. Immunol. Today 14,1,18–23
Herman J.A., Kew M.C., Rabson A.R. (1984). Defective interleukin-1 production by monocytes from patients with malignant diseases: interferon increases IL-1 production. Cancer Immunol. Immunotherap 16:182–5.
Hirano T., Akira S., Taga T. Hishimoto T. (1990) Biological and clinical aspects of interleukin 6. Immunology Today 11, (12) 443–449
Kastan J.B., Strauss L.C., Civin C.I. (1989) The role of hematopoietic growth factors and oncogenes in leukemogenesis. Am. J. Ped. Hem/Oncol. 11, 249–267.
Rosenstreich D., Haimovitz A., Brown K., Liao Z. (1987) Human interleukin 1 inhibitors. Lymphokines, ed. Edger Pick Academic Press inc 14,64
Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S.C., Dinarello C.A. (1990) Correlations and interactions in the production of interleukin-6 (IL-6), IL-1 and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75, 40–47
Tosato G., Jones K.D. (1990) Interleukin 1 induces interleukin-6 production in peripheral blood monocytes. Blood 75,(6), 1305–1310
Wardrop C.C.J., Holland B. (1992) Hematopoietic growth factors. Curr Opin Pediatr 4, 84–91
Wong G.C., Clark S.C., (1988) Multiple actions of interleukin 6 within a cytokine network. Immunology Today 9,(5)
Zimecki M., Wieczorek Z. (1987) IL-1 decreases the level of thymocytes forming rosettes with autologous erythrocytes, a new method of determination of IL-1 activity. Arch Immunol Ther Exp (Warsz) 355: 371.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Chybicka, A., Salwa, J., Jaworski, W., Radzikowski, C., Boguslawska-Jaworska, J. (1997). Interleukins (IL-1, IL-2, IL-4, IL6) and TNF Production in Children with Acute Lymphoblastic Leukemia. In: Büchner, T., Schellong, G., Ritter, J., Creutzig, U., Hiddemann, W., Wörmann, B. (eds) Acute Leukemias VI. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 38. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60377-8_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-60377-8_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64379-8
Online ISBN: 978-3-642-60377-8
eBook Packages: Springer Book Archive